Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00364 | Fmoc-Val-Cit-PAB | 159858-22-7 |
| Fmoc-Val-Cit-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00366 | N-SMP | 55750-61-3 |
| N-SMP is a potent synthetic compound known for its efficacy against various neurological disorders. As a powerful inhibitor, this compound specifically targets key enzymes involved in the progression of these debilitating diseases. In addition, N-SMP is also widely used as a linker for antibody-drug conjugation. | Inquiry | |
| BADC-00369 | Fmoc-Val-Cit-PAB-PNP | 863971-53-3 |
| Fmoc-Val-Cit-PAB-PNP is a cleavable linker bearing Fmoc protection, used in ADC payload design and targeted therapies. | Inquiry | |
| BADC-00372 | SPDP | 68181-17-9 |
| SPDP is a heterobifunctional crosslinker used for protein modification and antibody conjugation in biochemistry. | Inquiry | |
| BADC-00373 | 2,5-dioxopyrrolidin-1-yl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | 890409-85-5 |
| This product is a reactive NHS ester used for efficient coupling in advanced bioconjugation strategies. | Inquiry | |
| BADC-00374 | m-C-tri(CH2-PEG1-NHS ester) | 173414-89-6 |
| m-C-tri(CH2-PEG1-NHS ester) signifies a multifaceted and utilitarian agent extensively employed within the realm of biomedicine. Its profound versatility lies in its adeptness as a reactive entity, facilitating the intricate conjugation of pharmaceuticals or biomolecular entities to meticulously designated targets. | Inquiry | |
| BADC-00382 | Bis-PEG1-NHS ester | 65869-64-9 |
| Bis-PEG1-NHS ester is a non-cleavable 1-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00405 | NHS-PEG4-azide | 944251-24-5 |
| NHS-PEG4-azide is a non-cleavable 4-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00409 | Azido-PEG2-NHS ester | 1312309-64-0 |
| Azido-PEG2-NHS ester is a non-cleavable 2-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00410 | 6-Azidohexanoic acid NHS ester | 866363-70-4 |
| A noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00415 | BCN-PEG4-NHS ester | 1702356-19-1 |
| BCN-endo-PEG4-NHS is an ADC Linker containing 4 PEG units. | Inquiry | |
| BADC-00453 | Mal-PEG2-NHS ester | 1433997-01-3 |
| Mal-PEG2-NHS ester is a non-cleavable ADC linker containing the Maleimide group, 2-unit PEG, and NHS ester. | Inquiry | |
| BADC-00466 | 2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 663598-98-9 |
| NO2-SPDMV is a biomedical product used in the drug development of various diseases. With its unique chemical structure, it exhibits potential therapeutic properties to target specific receptors and enzymes involved in the progression of certain disorders. Its applications include drug research to treat cardiovascular disease, neurological diseases, and inflammatory diseases, among others. | Inquiry | |
| BADC-00477 | 1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid | 1193111-39-5 |
| This product is a sulfonic acid-functionalized reagent designed for disulfide-based linker chemistry and bioconjugation. | Inquiry | |
| BADC-00498 | Propargyl-NHS Ester | 1174157-65-3 |
| Propargyl-NHS ester is an indispensable small molecule tool in the biomedical field and is a key coupling agent that promotes bioconjugation reactions. This compound labels a range of biomolecules including proteins and peptides, facilitating their unambiguous identification and meticulous monitoring. With its sheer versatility, Propargyl-NHS Ester coordinates a range of tasks, including drug delivery systems, diagnostics and targeted therapies. | Inquiry | |
| BADC-00501 | Mc-Val-Cit-PABC-PNP | 159857-81-5 |
| Mc-Val-Cit-PABC-PNP is a self-immolative linker designed for controlled drug release in ADC and prodrug systems. | Inquiry | |
| BADC-00510 | (S)-di-tert-butyl 2-(3-((S)-6-amino-1-tert-butoxy-1-oxohexan-2-yl)ureido)pentanedioate | 1025796-31-9 |
| (S)-Di-tert-butyl 2-(3-((S)-6-amino-1-tert-butoxy-1-oxohexan-2-yl)ureido)pentanedioate is a PEG linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00511 | DUPA(OtBu)-OH | 1026987-94-9 |
| DUPA(OtBu)-OH is a PEG linker for antibody-drug-conjugation (ADC). DUPA(OtBu)-OH is a DUPA precursor. DUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer. | Inquiry | |
| BADC-00610 | Mc-Val-Cit-PAB-Cl | 1639351-92-0 |
| Inquiry | ||
| BADC-00615 | JUN68744 | 1703768-74-4 |
| JUN68744 is a useful peptide linker for synthesis of PSMA-617 (vipivotide tetraxetan), which is a ligand used to make 177Lu-PSMA-617, a radioactive molecule to fight cancer. PSMA-617 originally was developed at the German Cancer Research Center and the Heidelberg University Hospital. ABX held the exclusive license to bring the treatment, which targets prostate-specific membrane antigen (PSMA), through early clinical development. | Inquiry |
